The company's move to reduce the overall use of antibiotics marks another step in its shift towards more natural food sourcing.
Analysts and experts have begun to warm to the modernization plan that CEO Easterbrook has slated to reinvigorate MCD into the coming years.
Analysts say the old standby could end up as a market leader based on its historical resilience in tough markets and its aggressive remodeling efforts.
Kraft Heinz and DowDuPont spinoff Chemours offer attractive dividends and value potential.
Walmart's price compression could prove problematic ahead of its key sales season.
What you need to know ahead of the announcement of Starbucks' fourth-quarter results.
There is clear divergence between the best and the worst performers in each sector this earnings season.
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
There was a shift to buying the name in September, but traders should wait for more strength before jumping in.
Only buy these names if you like the fundamentals, don't count on these activist managers to make you money.